Objectives Intravenous immunoglobulin (IVIG) is commonly used to treat severe COVID-19,
although the clinical outcome of such treatment remains unclear. This study evaluated the …

Objectives At the present time, there is an absence of any proven effective antiviral therapy
for patients with coronavirus disease 2019 (COVID-19). The aim of this study was to assess …

Abstract Objective Coronavirus disease 2019 (COVID‐19) outbreak is a major challenge all
over the world, without acknowledged treatment. Intravenous immunoglobulin (IVIG) has …

Background Various immunomodulatory therapies have been explored to manage the
dysregulated immune response seen in severe COVID-19 infection. The objective of this …

Background During the COVID-19 pandemic, different treatments have been used in
critically ill patients. Using intravenous immunoglobulin (IVIG) has been suggested in …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has become a huge obstacle
to the health system due to the high rate of contagion. It is postulated that intravenous …

Background The clinical benefits of high-dose intravenous immunoglobulin (IVIg) in treating
COVID-19 remained controversial. Methods We systematically searched databases up to …

Intravenous immunoglobulin (IVIg) therapy has been suggested as a potential treatment
option for hospitalised COVID‐19 patients. The aim of this systematic review and meta …

Abstract Background Intravenous immunoglobulins (IVIg) have been used in management
of severe Covid-19. Here in this study, we report our single-center experience regarding IVIg …

Background The effective treatment of coronavirus disease 2019 (COVID-19) remains
unclear. We reported successful use of high-dose intravenous immunoglobulin (IVIg) in …